GLP-1
Price must be right to list GLP-1s
Government committed to working with industry stakeholders and patients to support safe and sustainable access to medicines through the PBS, Minister says An agreement on pricing is needed before glucagon-like peptide-1 (GLP-1) …
World news wrapup – 7 May 2026
Big four consultancy firm announces plans to drop funding for GLP-1s for staff, unless they have diabetes; push for increased dispensing fees as German pharmacies go out of business; North …
Research Roundup
Debbie Rigby rounds up the latest research news GLP-1 Receptor/Dual Agonists for Weight Loss A systematic review and network meta-analysis of 127 RCTs concluded that tirzepatide and semaglutide are most …
Wholesaler forecasts multi-year growth for GLP-1s
Glucagon-like peptide-1 medications are already delivering significant growth for wholesalers, but the best is yet to come, Symbion’s chief executive says Uptake of glucagon-like peptide-1 (GLP-1) products in Australia is on track for significant …
Consumer focus on health to benefit pharmacy: Macquarie
GLP-1s and front-of-shop health and beauty to drive growth in the Australian pharmacy market Community pharmacies are set to benefit from consumers’ focus on health in the post-Covid-19 environment, analysts …